Cytotoxicity of chlorhexidine digluconate to murine macrophages and its effect on hydrogen peroxide and nitric oxide induction

Chlorhexidine, even at low concentrations, is toxic for a variety of eukaryotic cells; however, its effects on host immune cells are not well known. We evaluated in vitro chlorhexidine-induced cytotoxicity and its effects on reactive oxygen/nitrogen intermediate induction by murine peritoneal macrophages. Thioglycollate-induced cells were obtained from Swiss mice by peritoneal lavage with 5 ml of 10 mM phosphate-buffered saline, washed twice and resuspended (10(6) cells/ml) in appropriate medium for each test. Cell preparations contained more than 95% macrophages. The cytotoxicity was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide assay and the presence of hydrogen peroxide (H2O2) and nitric oxide (NO) by the horseradish peroxidase-dependent oxidation of phenol red and Griess reaction, respectively. The midpoint cytotoxicity values for 1- and 24-h exposures were 61.12 ± 2.46 and 21.22 ± 2.44 µg/ml, respectively. Chlorhexidine did not induce synthesis or liberation of reactive oxygen/nitrogen intermediates. When macrophages were treated with various sub-toxic doses for 1 h (1, 5, 10, and 20 µg/ml) and 24 h (0.5, 1, and 5 µg/ml) and stimulated with 200 nM phorbol myristate acetate (PMA) solution, the H2O2 production was not altered; however, the NO production induced by 10 µg/ml lipopolysaccharide (LPS) solution varied from 14.47 ± 1.46 to 22.35 ± 1.94 µmol/l and 13.50 ± 1.42 to 20.44 ± 1.40 µmol/l (N = 5). The results showed that chlorhexidine has no immunostimulating activity and sub-toxic concentrations did not affect the response of macrophages to the soluble stimulus PMA but can interfere with the receptor-dependent stimulus LPS

Streptococcus Agalactiae In Brazil: Serotype Distribution, Virulence Determinants And Antimicrobial Susceptibility

Background: Group B Streptococcus (GBS) remains a major cause of neonatal sepsis and is also associated with invasive and noninvasive infections in pregnant women and non-pregnant adults, elderly and patients with underlying medical conditions. Ten capsular serotypes have been recognized, and determination of their distribution within a specific population or geographical region is important as they are major targets for the development of vaccine strategies. We have evaluated the characteristics of GBS isolates recovered from individuals with infections or colonization by this microorganism, living in different geographic regions of Brazil.Methods: A total of 434 isolates were identified and serotyped by conventional phenotypic tests. The determination of antimicrobial susceptibility was performed by the disk diffusion method. Genes associated with resistance to erythromycin (ermA, ermB, mefA) and tetracycline (tetK, tetL, tetM, tetO) as well as virulence-associated genes (bac, bca, lmb, scpB) were investigated using PCR. Pulsed-field gel electrophoresis (PFGE) was used to examine the genetic diversity of macrolide-resistant and of a number of selected macrolide-susceptible isolates.Results: Overall, serotypes Ia (27.6%), II (19.1%), Ib (18.7%) and V (13.6%) were the most predominant, followed by serotypes IV (8.1%) and III (6.7%). All the isolates were susceptible to the beta-lactam antimicrobials tested and 97% were resistant to tetracycline. Resistance to erythromycin and clindamycin were found in 4.1% and 3% of the isolates, respectively. Among the resistance genes investigated, tetM (99.3%) and tetO (1.8%) were detected among tetracycline-resistant isolates and ermA (39%) and ermB (27.6%) were found among macrolide-resistant isolates. The lmb and scpB virulence genes were detected in all isolates, while bac and bca were detected in 57 (13.1%) and 237 (54.6%) isolates, respectively. Molecular typing by PFGE showed that resistance to erythromycin was associated with a variety of clones.Conclusion: These findings indicate that GBS isolates circulating in Brazil have a variety of phenotypic and genotypic characteristics, and suggest that macrolide-resistant isolates may arise by both clonal spread and independent acquisition of resistance genes. © 2014 Dutra et al.; licensee BioMed Central Ltd.141Schuchat, A., Epidemiology of group B streptococcal disease in the United States: shifting paradigms (1998) Clin Microbiol Rev, 11, pp. 497-513. , 88893, 9665980Skoff, T.H., Farley, M.M., Petit, S., Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007 (2009) Clin Infect Dis, 49, pp. 85-92. , 10.1086/599369, 19480572Maisey, H.C., Doran, K.S., Nizet, V., Recent advances in understanding the molecular basis of group B Streptococcus virulence (2008) Expert Rev Mol Med, 10, pp. 1-16Slotved, H.C., Kong, F., Lambertsen, L., Sauer, S., Gilbert, G.L., Serotype IX, a proposed new Streptococcus agalactiae serotype (2007) J Clin Microbiol, 9, pp. 2929-2936Baker, C.J., Edwards, M.S., Group B streptococcal conjugate vaccines (2003) Arch Dis Child, 88, pp. 375-378. , 10.1136/adc.88.5.375, 1719562, 12716700Dogan, B., Schukken, Y.H., Santisteban, C., Boor, K.J., Distribuition of serotypes and antimicrobial resistance genes among Streptococcus agalactiae isolates from bovine and human hosts (2005) J Clin Microbiol, 43, pp. 5899-5906. , 10.1128/JCM.43.12.5899-5906.2005, 1317170, 16333073Luan, S.-L., Granlund, M., Sellin, M., Lagergard, T., Spratt, B.G., Norgren, M., Multilocus sequence typing of Swedish invasive group B Streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching (2005) J Clin Microbiol, 43, pp. 3727-3733. , 10.1128/JCM.43.8.3727-3733.2005, 1233917, 16081902Gherardi, G., Imperi, M., Baldassarri, L., Pataracchia, M., Alfarone, G., Recchia, S., Orefici, G., Creti, R., Molecular epidemiology and distribuition of serotypes, surface proteins, and antibiotic resistance among Group B streptococci in Italy (2007) J Clin Microbiol, 9, pp. 2909-2916Kim, E., Hans, C.S., Hans, V.N., Marcit, S.K., Helle, B.K., Emergence of invasive serotype VIII group B streptococcal infections in Denmark (2003) J Clin Microbiol, 41, pp. 4442-4444. , 10.1128/JCM.41.9.4442-4444.2003, 193804, 12958288Benchetrit, L.C., Fracalanzza, S.E.L., Peregrino, H., Camelo, A.A., Sanches, L.A.L.R., Carriage of Streptococcus agalactiae in women and neonates and distribution of serological types: a study in Brazil (1982) J Clin Microbiol, 15, pp. 787-790. , 272190, 7047552Duarte, R.S., Bellei, B.C., Miranda, O.P., Brito, M.A., Teixeira, L.M., Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources (2005) Antimicrob Agents Chemother, 49, pp. 97-103. , 10.1128/AAC.49.1.97-103.2005, 538850, 15616281Simões, J.A., Alves, V.M., Fracalanzza, S.E.L., Camargo, R.P., Mathias, H.M., Brolazo, E.M., Phenotypical characteristics of group B Streptococcus in parturients (2007) Braz J Infect Dis, 11, pp. 261-266. , 10.1590/S1413-86702007000200019, 17625774Palmeiro, J.K., Dalla-Costa, L.M., Fracalanzza, S.E.L., Botelho, A.C.N., Nogueira, K.S., Scheffer, M.C., Torres, A.R.L.S., Madeira, H.M.F., Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil (2010) J Clin Microbiol, 12, pp. 4397-4403Corrêa, A.B.A., Silva, G.L., Pinto, T.C.A., Oliveira, I.C.M., Fernandes, F.G., Costa, N.S., Mattos, M.C., Benchetrit, L.C., The genetic diversity and phenotypic characterisation of Streptococcus agalactiae isolates from Rio de Janeiro, Brazil (2011) Mem Inst Oswaldo Cruz, 106, pp. 1002-1006. , 10.1590/S0074-02762011000800017, 22241124Pinto, T.C.A., Costa, N.S., Souza, A.R.V., Silva, L.G., Corrêa, A.B.A., Fernandes, F.G., Oliveira, I.C.M., Benchetrit, L.C., Distribution of serotypes and evaluation of antimicrobial susceptibility among humam and bovine Streptococcus agalactiae strains isolated in Brazil between 1980 and 2006 (2013) Braz J Infect Dis, 17, pp. 131-136. , 10.1016/j.bjid.2012.09.006, 23453948Kimura, K., Suzuki, S., Wachino, J., Kurokawa, H., Yamane, K., Shibata, N., Nagano, N., Arakawa, Y., First molecular characterization of group B streptococci with reduced penicillin susceptibility (2008) Antimicrob Agents Chemother, 52, pp. 2890-2897. , 10.1128/AAC.00185-08, 2493108, 18490507Dahesh, S., Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics (2008) Antimicrob Agents Chemother, 52, pp. 2915-2918. , 10.1128/AAC.00461-08, 2493126, 18541727Nagano, N., Nagano, Y., Toyama, M., Kimura, K., Tamura, T., Shibayama, K., Arakawa, Y., Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1 (2012) J Antimicrob Chemother, 67, pp. 849-856. , 10.1093/jac/dkr546, 22210756Prevention of perinatal group B streptococcal disease: revised guidelines from CDC (2010) MMWR Recomm Rep, 59, pp. 1-31. , RR-10, CDC- Centers for Disease Control and PreventionGonzalez, J.J., Andreu, A., Multicenter study of the mechanisms of resistance and clonal relationships of Streptococcus agalactiae isolates resistant to macrolides, lincosamides, and ketolides in Spain (2005) Antimicrob Agents Chemother, 49, pp. 2525-2527. , 10.1128/AAC.49.6.2525-2527.2005, 1140544, 15917563, The spanish group for the study of perinatal infection from the spanish society for clinical microbiology and infectious diseasesHsush, P.R., Teng, L.J., Lee, L.N., HO, S.W., Yang, P.C., Luh, K.T., High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan (2001) Antimicrob Agents Chemother, 45, pp. 3205-3208. , 10.1128/AAC.45.11.3205-3208.2001, 90806, 11600380Desjardins, M., Delgaty, K.L., Ramotar, K., Seetaram, C., Toye, B., Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus implications for reporting susceptibility results (2004) J Clin Microbiol, 42, pp. 5620-5623. , 10.1128/JCM.42.12.5620-5623.2004, 535282, 15583291Borchardt, S.M., Debusscher, J.H., Tallman, P.A., Manning, S.D., Marrs, C.F., Kurzynski, T.A., Foxman, B., Frequency of antimicrobial resistance among invasive and colonizing Group B streptococcal isolates (2006) BMC Infect Dis, 6, p. 57. , 10.1186/1471-2334-6-57, 1435911, 16549015Phares, C.R., Lynfield, R., Farley, M.M., Mohle-Boetani, L.H., Petit, S., Craig, A.S., Schaffner, W., Schrag, S.J., Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005 (2008) JAMA, 299, pp. 2056-2065. , 10.1001/jama.299.17.2056, 18460666Martinez, M.A., Ovalle, S.A., Duran, C., Reid, I., Urriola, G., Garay, B., Cifuents, M., Sorotipos y susceptibilidad antimicrobiana de Streptococcus agalactiae (2004) Rev Méd Chil, 132, pp. 549-555Performance standards for antimicrobial susceptibility testing: approved standard (2010) 20th informational supplement Wayne, , PA: CLSI, M100-S20U, CLSISutcliffe, J., Grebe, T., Tait-Kamradt, A., Wondrack, L., Detection of erythromycin-resistant determinants by PCR (1996) Antimicrob Agents Chemother, 40, pp. 2562-2566. , 163576, 8913465Trzcinski, K., Cooper, B.S., Hryniewicz, W., Dowson, C.G., Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus (2000) J Antimicrob Chemother, 45, pp. 2778-2781Dmitriev, A., Shakleina, E., Tkacikova, M., Mikula, I., Totolian, Genetic heterogeneity of the pathogenic potentials of human and bovine group B streptococci (2002) Folia Microbiol, 47, pp. 291-295Corrêa, A.B.A., Oliveira, I.C.M., Pinto, T.C.A., Mattos, M.C., Benchetrit, L.C., Pulsed-field gel electrophoresis, virulence determinants and antimicrobial susceptibility profiles of type Ia group B streptococci isolated from humans in Brazil (2009) Mem Inst Oswaldo Cruz, 104, pp. 599-603. , 10.1590/S0074-02762009000400011, 19722083Teixeira, L.M., Carvalho, M.G.C., Merquior, V.L.C., Steigerwalt, A.G., Brenner, D.J., Facklam, R.R., Phenotypic and genotypic characterization of Vagococcus fluvialis, including strains isolates from human source (1997) J Clin Microbiol, 35, pp. 2778-2781. , 230060, 9350732Hunter, P.R., Gaston, M.A., Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity (1988) J Clin Microbiol, 26, pp. 2465-2466. , 266921, 3069867Grundmann, H., Hori, S., Tanner, G., Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms (2001) J Clin Microbiol, 39, pp. 4190-4192. , 10.1128/JCM.39.11.4190-4192.2001, 88515, 11682558Andrews, J.L., Diekema, D.J., Hunter, S.K., Rhomberg, P.R., Pfaller, M.A., Jones, R.N., Doern, G.V., Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere (2000) Am J Obstet Gynecol, 183, pp. 859-862. , 10.1067/mob.2000.108839, 11035326João, E.C., Gouvea, M.I., Menezes, J.A., Matos, H.J., Cruz, M.L.S., Rodrigues, C.A.S., Caio, A.S.R., Grinsztejn, B.G.J., Group B Streptococcus in a cohort of HIV-infected pregnant women: Prevalence of colonization, identification and antimicrobial susceptibility profile (2011) Scand J Infect Dis, 43, pp. 742-746Martins, E.R., Melo-Cristino, J., Ramirez, M., Dominance of serotype Ia among group B streptococci causing invasive infections in nonpregnant adults in Portugal (2012) J Clin Microbiol, 50, pp. 1219-1227. , 10.1128/JCM.05488-11, 3318525, 22219307Otaguiri, E.S., Morguette, A.E.B., Tavares, E.R., Santos, P.M.M.C., Morey, A.T., Cardoso, J.D., Perugini, M.R.E., Yamada-Ogatta, S.F., Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Paraná, Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinants (2013) BMC Microbiol, 13, pp. 297-305. , 10.1186/1471-2180-13-297, 3878097, 24359590Nakamura, P.A.M., Schuab, R.B.B., Neves, F.P.G., Pereira, C.F.A., de Paula, G.R., Barros, R.R., Antimicrobial resistance profiles and genetic characterisation of macrolide resistant isolates of Streptococcus agalactiae (2011) Mem Inst Oswaldo Cruz, 106, pp. 119-122. , 10.1590/S0074-02762011000200001, 21537668Culebras, E., Rodriguez-Avial, I., Betriu, C., Redondo, M., Picazo, J., Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae (2002) Antimicrob Agents Chemother, 5, pp. 1574-1576Roberts, M.C., Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes (2008) FEMS Microbiol Lett, 282, pp. 147-159. , 10.1111/j.1574-6968.2008.01145.x, 18399991Souza, V.C., Kegele, F.C., Souza, S.R., Neves, F.P., de Paula, G.R., Barros, R.R., Antimicrobial susceptibility and genetic diversity of Streptococcus agalactiae recovered from newborns and pregnant women in Brazil (2013) Scand J Infect Dis, 45, pp. 780-785. , 10.3109/00365548.2013.810814, 23876189Pillai, P., Srinivasan, U., Zhang, L., Borchardt, S.M., Debusscher, J., Marrs, C.F., Foxman, B., Streptococcus agalactiae pulsed-field gel electrophoresis patterns cross capsular types (2009) Epidemiol Infect, 137, pp. 1420-1425. , 10.1017/S0950268809002167, 3703924, 19257912Martins, E.R., Andreu, A., Correia, P., Juncosa, T., Bosch, J., Ramirez, M., Melo-Cristino, J., Group B streptococci causing neonatal infections in Barcelona are a stable clonal population: 18-year surveillance (2011) J Clin Microbiol, 49, pp. 2911-2918. , 10.1128/JCM.00271-11, 3147731, 21697333, Catalan Society for Clinical Microbiology and Infectious Disease